Nightingale

Closed

App for managing care of autistic students

San Francisco, United States · $6.7M raised

Employees
1–10
Total Funding
$6.7M
Last Round
$6.0M Series AMar 2015
Rounds
2

About

Nightingale is the clinical decision support solution for evidence-based interventions. We're committed to ensuring that service providers for individuals with autism and related disorders are equipped to administer high quality, personalized treatment. According to the CDC, 1 in 68 children in the U.S. are now diagnosed with autism, contributing to an estimated 1.5 million Americans living with the condition. Although autism has no known cure or scientifically proven pharmaceutical treatment, its symptoms can be abated and maintained through rigorous evidence-based interventions like applied behavior analysis, speech-language pathology, and occupational therapy. Nightingale provides these practitioners with a suite of tools for HIPAA-compliant data collection,reporting, and analytics that can be customized to any curriculum and used in any setting. By equipping service providers with a convenient and user-friendly solution for data management and analytics, Nightingale frees up more of their time for creating high-quality curriculums and working with clients.

Summary

Nightingale is an Education company based in San Francisco, United States. It has raised $6.7M in total across 2 rounds, most recently a $6.0M Series A round in Mar 2015. Investors include General Catalyst and Y Combinator Continuity Fund.

Tech & App Stack

4 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundMar 2015
$700K

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies